Insights

Loading spinner
Gathering insights about PepVax

PepVax Tech Stack

PepVax uses 8 technology products and services including Facebook Pixel, Vue.js, HeadJS, and more. Explore PepVax's tech stack below.

  • Facebook Pixel
    Analytics
  • Vue.js
    Javascript Frameworks
  • HeadJS
    Javascript Libraries
  • Marketo
    Marketing Automation
  • reCAPTCHA
    Security
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers
  • Facebook
    Widgets

PepVax's Email Address Formats

PepVax uses at least 1 format(s):
PepVax Email FormatsExamplePercentage
First.Last@pepvax.coJohn.Doe@pepvax.co
40%
FirLast@pepvax.coJohDoe@pepvax.co
20%
Last@pepvax.coDoe@pepvax.co
20%
First@pepvax.coJohn@pepvax.co
20%

Frequently Asked Questions

What is PepVax's phone number?

Minus sign iconPlus sign icon
You can contact PepVax's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PepVax's official website and social media links?

Minus sign iconPlus sign icon
PepVax's official website is pepvax.co and has social profiles on LinkedInCrunchbase.

What is PepVax's SIC code NAICS code?

Minus sign iconPlus sign icon
PepVax's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PepVax have currently?

Minus sign iconPlus sign icon
As of December 2025, PepVax has approximately employees across 1 continents, including North America. Key team members include . Explore PepVax's employee directory with LeadIQ.

What industry does PepVax belong to?

Minus sign iconPlus sign icon
PepVax operates in the Biotechnology Research industry.

What technology does PepVax use?

Minus sign iconPlus sign icon
PepVax's tech stack includes Facebook PixelVue.jsHeadJSMarketoreCAPTCHAApacheApache HTTP ServerFacebook.

What is PepVax's email format?

Minus sign iconPlus sign icon
PepVax's email format typically follows the pattern of First.Last@pepvax.co. Find more PepVax email formats with LeadIQ.

When was PepVax founded?

Minus sign iconPlus sign icon
PepVax was founded in 2013.

PepVax

Biotechnology ResearchMaryland, United States2-10 Employees

PepVax, Inc. is an early-stage biotechnology company developing a DNA-based drug delivery and development platform. Our novel DNA plasmid delivery system takes a simplified method to delivery and our “Trojan Horse” approach uses the patient’s own cells to manufacture the required proteins, T-cells and antibodies inside the patient (Intusic™) for cancers, infectious and genetic diseases. 

PepVax’s management team brings with it the ability to raise necessary funding, design in vitro trials in coordination with our outsourced partners, monitor the trials, and develop new technologies through cutting-edge research and development. Members of the management team have experience in setting up the necessary infrastructure for early-stage companies that will ultimately make them successful.

Manufacturing cell therapies, DNA, RNA and proteins ex vivo have always been a problem, especially in scale up and cost. The process takes weeks and in the case of cell therapies, it is very painful for the patient. With administration of externally manufactured drugs of these types, there are also strong possibilities for anti-drug-antibodies (ADAs) or over-acting immune responses leading to potential autoimmune reactions like cytokine storms.

Our SMARTmid™ Vector is designed to take manufacturing from outside the patient to inside the patient, using the patient's own cells to manufacture the necessary protein-, DNA- and RNA-based treatments. It is a fully synthetic method for producing plasmid vector particles for mammalian cell transduction and is a powerful template in which to build a drug delivery platform.

We are looking at academics and small biotechnology companies working on new NAA drugs as our first customers. We plan to establish collaborations and licensing agreements to develop the drugs on our delivery platform, which will create early licensing revenues and a pipeline for future revenue through milestone payments and royalties.

Section iconCompany Overview

Phone number
Website
pepvax.co
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $1M

    PepVax's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    PepVax's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.